Singer J I, Buchino J J, Chabali R
Emerg Med Clin North Am. 1986 May;4(2):377-96.
The superiority of either a complete blood count, erythrocyte sedimentation rate, or C-reactive protein as a generic, global screening test for bacterial infection in infants or children has not been clearly demonstrated. The few claims of superiority for one determination over another relate more to the clinical setting than marginal differences in sensitivity or specificity. Neither the complete blood count, erythrocyte sedimentation rate, or C-reactive protein has proved sensitive enough of predicting invasive bacterial infection that it can be used as an isolated measure upon which major management decisions can safely be based. Several investigators have therefore addressed whether these tests can complement each other. Unfortunately, acquisition of multiple nonspecific laboratory tests in a given clinical situation may yield widely divergent results. The C-reactive protein, complete blood count, erythrocyte sedimentation rate, and zeta sedimentation ratio are all comparably priced in the $15.00 to $30.00 range. However, if multiple tests are obtained, the cost of this approach may become unacceptably high. Current practice advocates a careful evaluation of an ill pediatric patient in an Emergency setting. The initial clinical impression of an experienced clinician based on history and physical examination frequently provides dependable information with which to direct subsequent evaluation. If bacterial infection ranks high on the differential list, relevant laboratory studies should be considered. Observation of quantitative and qualitative changes of the hematologic profile or rate of erythrocyte sedimentation are adequate tools in specific circumstances. With the resurgence of interest in the use of C-reactive protein, it too may join the ranks of convention in selected settings.
全血细胞计数、红细胞沉降率或C反应蛋白作为婴儿或儿童细菌感染的通用全面筛查试验,其优越性尚未得到明确证实。关于一种检测相对于另一种检测的优越性的少数说法,更多地与临床情况有关,而非敏感性或特异性的微小差异。全血细胞计数、红细胞沉降率或C反应蛋白均未被证明对预测侵袭性细菌感染足够敏感,以至于不能将其作为主要管理决策可安全依据的单独检测指标。因此,一些研究人员探讨了这些检测是否可以相互补充。不幸的是,在特定临床情况下进行多项非特异性实验室检测可能会得出差异很大的结果。C反应蛋白、全血细胞计数、红细胞沉降率和ζ沉降率的价格都在15.00美元至30.00美元的范围内。然而,如果进行多项检测,这种方法的成本可能会高得令人无法接受。目前的做法主张在急诊环境中对患病儿童患者进行仔细评估。经验丰富的临床医生基于病史和体格检查得出的初步临床印象常常能提供可靠信息,用以指导后续评估。如果细菌感染在鉴别诊断中可能性较大,就应考虑进行相关实验室检查。在特定情况下,观察血液学指标的定量和定性变化或红细胞沉降率是足够的工具。随着对使用C反应蛋白的兴趣再度兴起,在某些特定情况下,它也可能会成为常规检测项目之一。